Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 1
2013 4
2014 4
2015 3
2016 1
2018 2
2019 2
2020 5
2021 1
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
MiRNAs in renal cell carcinoma.
Miranda-Poma J, Trilla-Fuertes L, López-Camacho E, Zapater-Moros A, López-Vacas R, Lumbreras-Herrera MI, Pertejo-Fernandez A, Fresno-Vara JÁ, Espinosa-Arranz E, Gámez-Pozo A, Pinto-Marín Á. Miranda-Poma J, et al. Among authors: lopez camacho e. Clin Transl Oncol. 2022 Nov;24(11):2055-2063. doi: 10.1007/s12094-022-02866-z. Epub 2022 Jun 21. Clin Transl Oncol. 2022. PMID: 35729452 Review.
VIGLA-M: visual gene expression data analytics.
Navas-Delgado I, García-Nieto J, López-Camacho E, Rybinski M, Lavado R, Berciano Guerrero MÁ, Aldana-Montes JF. Navas-Delgado I, et al. Among authors: lopez camacho e. BMC Bioinformatics. 2019 Apr 18;20(Suppl 4):150. doi: 10.1186/s12859-019-2695-7. BMC Bioinformatics. 2019. PMID: 30999846 Free PMC article.
Proteomics Characterization of Clear Cell Renal Cell Carcinoma.
Miranda-Poma J, Trilla-Fuertes L, López-Vacas R, López-Camacho E, García-Fernández E, Pertejo A, Lumbreras-Herrera MI, Zapater-Moros A, Díaz-Almirón M, Dittmann A, Fresno Vara JÁ, Espinosa E, González-Peramato P, Pinto-Marín Á, Gámez-Pozo A. Miranda-Poma J, et al. Among authors: lopez camacho e. J Clin Med. 2023 Jan 3;12(1):384. doi: 10.3390/jcm12010384. J Clin Med. 2023. PMID: 36615183 Free PMC article.
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer.
López-Camacho E, Trilla-Fuertes L, Gámez-Pozo A, Dapía I, López-Vacas R, Zapater-Moros A, Lumbreras-Herrera MI, Arias P, Zamora P, Vara JÁF, Espinosa E. López-Camacho E, et al. Biomed Pharmacother. 2022 May;149:112844. doi: 10.1016/j.biopha.2022.112844. Epub 2022 Mar 23. Biomed Pharmacother. 2022. PMID: 35339109 Free article.
Bayesian networks established functional differences between breast cancer subtypes.
Trilla-Fuertes L, Gámez-Pozo A, Arevalillo JM, López-Vacas R, López-Camacho E, Prado-Vázquez G, Zapater-Moros A, Díaz-Almirón M, Ferrer-Gómez M, Navarro H, Nanni P, Zamora P, Espinosa E, Maín P, Fresno Vara JÁ. Trilla-Fuertes L, et al. Among authors: lopez camacho e. PLoS One. 2020 Jun 11;15(6):e0234752. doi: 10.1371/journal.pone.0234752. eCollection 2020. PLoS One. 2020. PMID: 32525929 Free PMC article.
Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomics.
García-Adrián S, Trilla-Fuertes L, Gámez-Pozo A, Chiva C, López-Vacas R, López-Camacho E, Zapater-Moros A, Lumbreras-Herrera MI, Hardisson D, Yébenes L, Zamora P, Sabidó E, Fresno Vara JÁ, Espinosa E. García-Adrián S, et al. Among authors: lopez camacho e. Proteomics. 2022 Feb;22(3):e2100110. doi: 10.1002/pmic.202100110. Epub 2021 Oct 27. Proteomics. 2022. PMID: 34624180
Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.
Zapater-Moros A, Díaz-Beltrán L, Gámez-Pozo A, Trilla-Fuertes L, Lumbreras-Herrera MI, López-Camacho E, González-Olmedo C, Espinosa E, Zamora P, Sánchez-Rovira P, Fresno Vara JÁ. Zapater-Moros A, et al. Among authors: lopez camacho e. Metabolomics. 2023 Jun 21;19(7):60. doi: 10.1007/s11306-023-02024-8. Metabolomics. 2023. PMID: 37344702
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.
Trilla-Fuertes L, Gámez-Pozo A, Lumbreras-Herrera MI, López-Vacas R, Heredia-Soto V, Ghanem I, López-Camacho E, Zapater-Moros A, Miguel M, Peña-Burgos EM, Palacios E, De Uribe M, Guerra L, Dittmann A, Mendiola M, Fresno Vara JÁ, Feliu J. Trilla-Fuertes L, et al. Among authors: lopez camacho e. Cancers (Basel). 2022 May 13;14(10):2414. doi: 10.3390/cancers14102414. Cancers (Basel). 2022. PMID: 35626021 Free PMC article.
28 results